Header Logo

Connection

Alan Schneyer to Inhibins

This is a "connection" page, showing publications Alan Schneyer has written about Inhibins.
Connection Strength

4.685
  1. Welt CK, Taylor AE, Fox J, Messerlian GM, Adams JM, Schneyer AL. Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis. J Clin Endocrinol Metab. 2005 Oct; 90(10):5582-7.
    View in: PubMed
    Score: 0.241
  2. del Re E, Sidis Y, Fabrizio DA, Lin HY, Schneyer A. Reconstitution and analysis of soluble inhibin and activin receptor complexes in a cell-free system. J Biol Chem. 2004 Dec 17; 279(51):53126-35.
    View in: PubMed
    Score: 0.229
  3. Schneyer A. Inhibins: a historical perspective. Semin Reprod Med. 2004 Aug; 22(3):161-4.
    View in: PubMed
    Score: 0.226
  4. Welt C, Sidis Y, Keutmann H, Schneyer A. Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium. Exp Biol Med (Maywood). 2002 Oct; 227(9):724-52.
    View in: PubMed
    Score: 0.199
  5. Fujiwara T, Sidis Y, Welt C, Lambert-Messerlian G, Fox J, Taylor A, Schneyer A. Dynamics of inhibin subunit and follistatin mRNA during development of normal and polycystic ovary syndrome follicles. J Clin Endocrinol Metab. 2001 Sep; 86(9):4206-15.
    View in: PubMed
    Score: 0.184
  6. Welt CK, Schneyer AL. Differential regulation of inhibin B and inhibin a by follicle-stimulating hormone and local growth factors in human granulosa cells from small antral follicles. J Clin Endocrinol Metab. 2001 Jan; 86(1):330-6.
    View in: PubMed
    Score: 0.176
  7. Schneyer AL, Fujiwara T, Fox J, Welt CK, Adams J, Messerlian GM, Taylor AE. Dynamic changes in the intrafollicular inhibin/activin/follistatin axis during human follicular development: relationship to circulating hormone concentrations. J Clin Endocrinol Metab. 2000 Sep; 85(9):3319-30.
    View in: PubMed
    Score: 0.172
  8. Fujiwara T, Lambert-Messerlian G, Sidis Y, Leykin L, Isaacson K, Toth T, Schneyer A. Analysis of follicular fluid hormone concentrations and granulosa cell mRNA levels for the inhibin-activin-follistatin system: relation to oocyte and embryo characteristics. Fertil Steril. 2000 Aug; 74(2):348-55.
    View in: PubMed
    Score: 0.171
  9. Delbaere A, Sidis Y, Schneyer AL. Differential response to exogenous and endogenous activin in a human ovarian teratocarcinoma-derived cell line (PA-1): regulation by cell surface follistatin. Endocrinology. 1999 Jun; 140(6):2463-70.
    View in: PubMed
    Score: 0.158
  10. Li Y, Fortin J, Ongaro L, Zhou X, Boehm U, Schneyer A, Bernard DJ, Lin HY. Betaglycan (TGFBR3) Functions as an Inhibin A, but Not Inhibin B, Coreceptor in Pituitary Gonadotrope Cells in Mice. Endocrinology. 2018 12 01; 159(12):4077-4091.
    View in: PubMed
    Score: 0.152
  11. Sidis Y, Fujiwara T, Leykin L, Isaacson K, Toth T, Schneyer AL. Characterization of inhibin/activin subunit, activin receptor, and follistatin messenger ribonucleic acid in human and mouse oocytes: evidence for activin's paracrine signaling from granulosa cells to oocytes. Biol Reprod. 1998 Oct; 59(4):807-12.
    View in: PubMed
    Score: 0.151
  12. Di Simone N, Hall HA, Welt C, Schneyer AL. Activin regulates betaA-subunit and activin receptor messenger ribonucleic acid and cellular proliferation in activin-responsive testicular tumor cells. Endocrinology. 1998 Mar; 139(3):1147-55.
    View in: PubMed
    Score: 0.145
  13. Welt CK, Lambert-Messerlian G, Zheng W, Crowley WF, Schneyer AL. Presence of activin, inhibin, and follistatin in epithelial ovarian carcinoma. J Clin Endocrinol Metab. 1997 Nov; 82(11):3720-7.
    View in: PubMed
    Score: 0.141
  14. Lambert-Messerlian G, Taylor A, Leykin L, Isaacson K, Toth T, Chang Y, Schneyer A. Characterization of intrafollicular steroid hormones, inhibin, and follistatin in women with and without polycystic ovarian syndrome following gonadotropin hyperstimulation. Biol Reprod. 1997 Nov; 57(5):1211-6.
    View in: PubMed
    Score: 0.141
  15. Lambert-Messerlian GM, Steinhoff M, Zheng W, Canick JA, Gajewski WH, Seifer DB, Schneyer AL. Multiple immunoreactive inhibin proteins in serum from postmenopausal women with epithelial ovarian cancer. Gynecol Oncol. 1997 Jun; 65(3):512-6.
    View in: PubMed
    Score: 0.137
  16. Schneyer AL. Measurement of activin in physiological fluids. Eur J Endocrinol. 1996 Apr; 134(4):401-2.
    View in: PubMed
    Score: 0.127
  17. Seifer DB, Lambert-Messerlian GM, Canick JA, Frishman GN, Schneyer AL. Serum inhibin levels are lower in ectopic than intrauterine spontaneously conceived pregnancies. Fertil Steril. 1996 Mar; 65(3):667-9.
    View in: PubMed
    Score: 0.126
  18. Di Simone N, Crowley WF, Wang QF, Sluss PM, Schneyer AL. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation. Endocrinology. 1996 Feb; 137(2):486-94.
    View in: PubMed
    Score: 0.125
  19. Seifer DB, Gardiner AC, Lambert-Messerlian G, Schneyer AL. Differential secretion of dimeric inhibin in cultured luteinized granulosa cells as a function of ovarian reserve. J Clin Endocrinol Metab. 1996 Feb; 81(2):736-9.
    View in: PubMed
    Score: 0.125
  20. Schneyer AL, Hall HA, Lambert-Messerlian G, Wang QF, Sluss P, Crowley WF. Follistatin-activin complexes in human serum and follicular fluid differ immunologically and biochemically. Endocrinology. 1996 Jan; 137(1):240-7.
    View in: PubMed
    Score: 0.125
  21. Lambert-Messerlian GM, Canick JA, Palomaki GE, Schneyer AL. Second trimester levels of maternal serum inhibin A, total inhibin, alpha inhibin precursor, and activin in Down's syndrome pregnancy. J Med Screen. 1996; 3(2):58-62.
    View in: PubMed
    Score: 0.125
  22. Lambert-Messerlian GM, Crowley WF, Schneyer AL. Extragonadal alpha-inhibin precursor proteins circulate in human male serum. J Clin Endocrinol Metab. 1995 Oct; 80(10):3043-9.
    View in: PubMed
    Score: 0.122
  23. Schneyer AL, Rzucidlo DA, Sluss PM, Crowley WF. Characterization of unique binding kinetics of follistatin and activin or inhibin in serum. Endocrinology. 1994 Aug; 135(2):667-74.
    View in: PubMed
    Score: 0.113
  24. Lambert-Messerlian GM, Hall JE, Sluss PM, Taylor AE, Martin KA, Groome NP, Crowley WF, Schneyer AL. Relatively low levels of dimeric inhibin circulate in men and women with polycystic ovarian syndrome using a specific two-site enzyme-linked immunosorbent assay. J Clin Endocrinol Metab. 1994 Jul; 79(1):45-50.
    View in: PubMed
    Score: 0.112
  25. Lambert-Messerlian GM, Isaacson K, Crowley WF, Sluss P, Schneyer AL. Human follicular fluid contains pro- and C-terminal immunoreactive alpha-inhibin precursor proteins. J Clin Endocrinol Metab. 1994 Feb; 78(2):433-9.
    View in: PubMed
    Score: 0.109
  26. Sluss PM, Gentile DP, Ewing JF, Schoen SR, Cockett AT, Martin KA, Schneyer AL. Multiple molecular weight forms of immunoreactive alpha-inhibin in human seminal plasma. J Clin Endocrinol Metab. 1993 Feb; 76(2):476-83.
    View in: PubMed
    Score: 0.102
  27. Schneyer AL, O'Neil DA, Crowley WF. Activin-binding proteins in human serum and follicular fluid. J Clin Endocrinol Metab. 1992 Jun; 74(6):1320-4.
    View in: PubMed
    Score: 0.097
  28. Schneyer AL, Sluss PM, Whitcomb RW, Martin KA, Sprengel R, Crowley WF. Precursors of alpha-inhibin modulate follicle-stimulating hormone receptor binding and biological activity. Endocrinology. 1991 Oct; 129(4):1987-99.
    View in: PubMed
    Score: 0.093
  29. Bernstein JR, Crowley WF, Schneyer AL. An improved method of purifying inhibin radioligand for radioimmunoassay. Biol Reprod. 1990 Sep; 43(3):492-6.
    View in: PubMed
    Score: 0.086
  30. Schneyer AL, Mason AJ, Burton LE, Ziegner JR, Crowley WF. Immunoreactive inhibin alpha-subunit in human serum: implications for radioimmunoassay. J Clin Endocrinol Metab. 1990 Apr; 70(4):1208-12.
    View in: PubMed
    Score: 0.084
  31. Lambert-Messerlian GM, Pinar H, Laprade E, Tantravahi U, Schneyer A, Canick JA. Inhibins and activins in human fetal abnormalities. Mol Cell Endocrinol. 2004 Oct 15; 225(1-2):101-8.
    View in: PubMed
    Score: 0.057
  32. Tortoriello DV, Sidis Y, Holtzman DA, Holmes WE, Schneyer AL. Human follistatin-related protein: a structural homologue of follistatin with nuclear localization. Endocrinology. 2001 Aug; 142(8):3426-34.
    View in: PubMed
    Score: 0.046
  33. Sidis Y, Schneyer AL, Sluss PM, Johnson LN, Keutmann HT. Follistatin: essential role for the N-terminal domain in activin binding and neutralization. J Biol Chem. 2001 May 25; 276(21):17718-26.
    View in: PubMed
    Score: 0.045
  34. Wang Q, Keutmann HT, Schneyer AL, Sluss PM. Analysis of human follistatin structure: identification of two discontinuous N-terminal sequences coding for activin A binding and structural consequences of activin binding to native proteins. Endocrinology. 2000 Sep; 141(9):3183-93.
    View in: PubMed
    Score: 0.043
  35. Zheng W, Luo MP, Welt C, Lambert-Messerlian G, Sung CJ, Zhang Z, Ying SY, Schneyer AL, Lauchlan SC, Felix JC. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer. Gynecol Oncol. 1998 Apr; 69(1):23-31.
    View in: PubMed
    Score: 0.036
  36. McConnell DS, Wang Q, Sluss PM, Bolf N, Khoury RH, Schneyer AL, Midgley AR, Reame NE, Crowley WF, Padmanabhan V. A two-site chemiluminescent assay for activin-free follistatin reveals that most follistatin circulating in men and normal cycling women is in an activin-bound state. J Clin Endocrinol Metab. 1998 Mar; 83(3):851-8.
    View in: PubMed
    Score: 0.036
  37. Wang QF, Tilly KI, Tilly JL, Preffer F, Schneyer AL, Crowley WF, Sluss PM. Activin inhibits basal and androgen-stimulated proliferation and induces apoptosis in the human prostatic cancer cell line, LNCaP. Endocrinology. 1996 Dec; 137(12):5476-83.
    View in: PubMed
    Score: 0.033
  38. Besecke LM, Guendner MJ, Schneyer AL, Bauer-Dantoin AC, Jameson JL, Weiss J. Gonadotropin-releasing hormone regulates follicle-stimulating hormone-beta gene expression through an activin/follistatin autocrine or paracrine loop. Endocrinology. 1996 Sep; 137(9):3667-73.
    View in: PubMed
    Score: 0.033
  39. Good TE, Weber PS, Ireland JL, Pulaski J, Padmanabhan V, Schneyer AL, Lambert-Messerlian G, Ghosh BR, Miller WL, Groome N, et al. Isolation of nine different biologically and immunologically active molecular variants of bovine follicular inhibin. Biol Reprod. 1995 Dec; 53(6):1478-88.
    View in: PubMed
    Score: 0.031
  40. Santoro N, Schneyer AL, Ibrahim J, Schmidt CL. Gonadotropin and inhibin concentrations in early pregnancy in women with and without corpora lutea. Obstet Gynecol. 1992 Apr; 79(4):579-85.
    View in: PubMed
    Score: 0.024
  41. Wang QF, Khoury RH, Smith PC, McConnell DS, Padmanahban V, Midgley AR, Schneyer AL, Crowley WF, Sluss PM. A two-site monoclonal antibody immunoradiometric assay for human follistatin: secretion by a human ovarian teratocarcinoma-derived cell line (PA-1). J Clin Endocrinol Metab. 1996 Apr; 81(4):1434-41.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.